Karachi: S.G. Power Limited, a notable entity within Pakistan's industrial landscape, announced a significant shift in its business operations, transitioning from the power generation sector to the pharmaceutical and healthcare industry. This development was officially reported on June 29, 2026, as the company completed the necessary corporate and regulatory processes.

The transition follows the approval of a Special Resolution by the company's members during an Extraordinary General Meeting on May 13, 2026. This was further substantiated by the registration of pertinent statutory filings with the Securities and Exchange Commission of Pakistan (SECP), leading to the formal change in the company's principal line of business.

According to information available from the Pakistan Stock Exchange (PSX), S.G. Power Limited has now redefined its business focus to encompass the import, export, manufacture, distribution, marketing, sale, rental, installation, maintenance, and after-sales servicing of medical equipment, devices, hospital supplies, and related healthcare products. This extends to the manufacturing and trading of pharmaceutical and medicinal products, as outlined in the amended Memorandum of Association.

The company is in the process of aligning its corporate identity with its new operational focus. This involves undertaking necessary corporate and regulatory procedures to change its name, ensuring it accurately reflects its revised business activities. Once completed, S.G. Power Limited will notify the Pakistan Stock Exchange and other relevant stakeholders about the name change and its implications.

This strategic shift marks a pivotal milestone in the company's transformation, setting the groundwork for exploring opportunities within Pakistan's burgeoning healthcare and pharmaceutical sectors. S.G. Power Limited has committed to keeping the Exchange and its shareholders apprised of any further developments in compliance with regulatory obligations.